Cargando…
Development of Inactivated FAKHRAVAC(®) Vaccine against SARS-CoV-2 Virus: Preclinical Study in Animal Models
The recent viral infection disease pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in a global public health crisis. Iran, as one of the countries that reported over five million infected cases by September 2021, has been concerned with the urgent devel...
Autores principales: | Ghasemi, Soheil, Naderi Saffar, Kosar, Ebrahimi, Firooz, Khatami, Pezhman, Monazah, Arina, Alizadeh, Ghorban-Ali, Ettehadi, Hossein-Ali, Rad, Iman, Nojehdehi, Shahrzad, Kehtari, Mousa, Kouhkan, Fatemeh, Barjasteh, Hesam, Moradi, Sohrab, Ghorbani, Mohammad-Hosein, Khodaie, Ali, Papizadeh, Moslem, Najafi, Roghayeh, Naghneh, Ehsan, Sadeghi, Davood, Karimi Rahjerdi, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8622747/ https://www.ncbi.nlm.nih.gov/pubmed/34835202 http://dx.doi.org/10.3390/vaccines9111271 |
Ejemplares similares
-
Comparison of the Safety and Immunogenicity of FAKHRAVAC and BBIBP-CorV Vaccines when Administrated as Booster Dose: A Parallel Two Arms, Randomized, Double Blind Clinical Trial
por: Ahi, Mohammadreza, et al.
Publicado: (2022) -
Phase II randomized, double blind, placebo controlled, clinical trial of safety and immunogenicity of an inactivated SARS-CoV-2 vaccine FAKHRAVAC in adults aged 18–70 years
por: Gholami, Fatemeh, et al.
Publicado: (2023) -
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine (FAKHRAVAC®) in healthy adults aged 18–55 years: Randomized, double-blind, placebo-controlled, phase I clinical trial
por: Ansarifar, Akram, et al.
Publicado: (2023) -
Safety and efficacy of the FAKHRAVAC compared with BBIBP-Corv2 against SARS-CoV-2 in adults: a non-inferiority multi-center trial
por: Solaymani-Dodaran, Masoud, et al.
Publicado: (2023) -
Simultaneous regulation of miR-451 and miR-191 led to erythroid fate decision of mouse embryonic stem cell
por: Shokri, Gelareh, et al.
Publicado: (2019)